調査レポート | • レポートコード：QYR2104Z6079 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、132ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥553,800 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥830,700 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,107,600 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、女性健康診断のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（乳がん検査、子宮頸がん検査、骨粗鬆症検査、妊娠検査、受精能検査、卵巣がん検査、感染症検査、出生前遺伝子スクリーニング及び保因者検査、超音波検査、HIV検査）、用途別市場規模（診断及び画像センター、病院及び診療所、在宅医療）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・女性健康診断の市場動向 ・企業の競争状況、市場シェア ・女性健康診断の種類別市場規模（乳がん検査、子宮頸がん検査、骨粗鬆症検査、妊娠検査、受精能検査、卵巣がん検査、感染症検査、出生前遺伝子スクリーニング及び保因者検査、超音波検査、HIV検査） ・女性健康診断の用途別市場規模（診断及び画像センター、病院及び診療所、在宅医療） ・女性健康診断の北米市場規模2016-2027（アメリカ、カナダ） ・女性健康診断のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・女性健康診断のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・女性健康診断の中南米市場規模2016-2027（メキシコ、ブラジル） ・女性健康診断の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Quest Diagnostics、Abbott、BD、Roche、GE Healthcare、Biomerieux、Philips、DIALAB、Fujifilm、GenMark、Hologic、Luminex、Nova Biomedical、PerkinElmer、Siemens Healthineers） ・結論 |
Market Analysis and Insights: Global Women Health Diagnostics Market
The global Women Health Diagnostics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Women Health Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Women Health Diagnostics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Women Health Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Women Health Diagnostics market.
Global Women Health Diagnostics Scope and Market Size
Women Health Diagnostics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Women Health Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Breast cancer testing
Cervical cancer testing
Osteoporosis testing
Pregnancy & fertility testing
Ovarian cancer testing
Infectious disease testing
Prenatal genetic screening and carrier testing
Ultrasound tests
HIV testing
Segment by Application
Diagnostic and imaging centers
Hospitals and clinics
Home care
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Quest Diagnostics
Abbott
BD
Roche
GE Healthcare
Biomerieux
Philips
DIALAB
Fujifilm
Roche
GE Healthcare
Luminex
Nova Biomedical
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Women Health Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Breast cancer testing
1.2.3 Cervical cancer testing
1.2.4 Osteoporosis testing
1.2.5 Pregnancy & fertility testing
1.2.6 Ovarian cancer testing
1.2.7 Infectious disease testing
1.2.8 Prenatal genetic screening and carrier testing
1.2.9 Ultrasound tests
1.2.10 HIV testing
1.3 Market by Application
1.3.1 Global Women Health Diagnostics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Diagnostic and imaging centers
1.3.3 Hospitals and clinics
1.3.4 Home care
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Women Health Diagnostics Market Perspective (2016-2027)
2.2 Women Health Diagnostics Growth Trends by Regions
2.2.1 Women Health Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Women Health Diagnostics Historic Market Share by Regions (2016-2021)
2.2.3 Women Health Diagnostics Forecasted Market Size by Regions (2022-2027)
2.3 Women Health Diagnostics Industry Dynamic
2.3.1 Women Health Diagnostics Market Trends
2.3.2 Women Health Diagnostics Market Drivers
2.3.3 Women Health Diagnostics Market Challenges
2.3.4 Women Health Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Women Health Diagnostics Players by Revenue
3.1.1 Global Top Women Health Diagnostics Players by Revenue (2016-2021)
3.1.2 Global Women Health Diagnostics Revenue Market Share by Players (2016-2021)
3.2 Global Women Health Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Women Health Diagnostics Revenue
3.4 Global Women Health Diagnostics Market Concentration Ratio
3.4.1 Global Women Health Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Women Health Diagnostics Revenue in 2020
3.5 Women Health Diagnostics Key Players Head office and Area Served
3.6 Key Players Women Health Diagnostics Product Solution and Service
3.7 Date of Enter into Women Health Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Women Health Diagnostics Breakdown Data by Type
4.1 Global Women Health Diagnostics Historic Market Size by Type (2016-2021)
4.2 Global Women Health Diagnostics Forecasted Market Size by Type (2022-2027)
5 Women Health Diagnostics Breakdown Data by Application
5.1 Global Women Health Diagnostics Historic Market Size by Application (2016-2021)
5.2 Global Women Health Diagnostics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Women Health Diagnostics Market Size (2016-2027)
6.2 North America Women Health Diagnostics Market Size by Type
6.2.1 North America Women Health Diagnostics Market Size by Type (2016-2021)
6.2.2 North America Women Health Diagnostics Market Size by Type (2022-2027)
6.2.3 North America Women Health Diagnostics Market Size by Type (2016-2027)
6.3 North America Women Health Diagnostics Market Size by Application
6.3.1 North America Women Health Diagnostics Market Size by Application (2016-2021)
6.3.2 North America Women Health Diagnostics Market Size by Application (2022-2027)
6.3.3 North America Women Health Diagnostics Market Size by Application (2016-2027)
6.4 North America Women Health Diagnostics Market Size by Country
6.4.1 North America Women Health Diagnostics Market Size by Country (2016-2021)
6.4.2 North America Women Health Diagnostics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Women Health Diagnostics Market Size (2016-2027)
7.2 Europe Women Health Diagnostics Market Size by Type
7.2.1 Europe Women Health Diagnostics Market Size by Type (2016-2021)
7.2.2 Europe Women Health Diagnostics Market Size by Type (2022-2027)
7.2.3 Europe Women Health Diagnostics Market Size by Type (2016-2027)
7.3 Europe Women Health Diagnostics Market Size by Application
7.3.1 Europe Women Health Diagnostics Market Size by Application (2016-2021)
7.3.2 Europe Women Health Diagnostics Market Size by Application (2022-2027)
7.3.3 Europe Women Health Diagnostics Market Size by Application (2016-2027)
7.4 Europe Women Health Diagnostics Market Size by Country
7.4.1 Europe Women Health Diagnostics Market Size by Country (2016-2021)
7.4.2 Europe Women Health Diagnostics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Women Health Diagnostics Market Size (2016-2027)
8.2 Asia-Pacific Women Health Diagnostics Market Size by Type
8.2.1 Asia-Pacific Women Health Diagnostics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Women Health Diagnostics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Women Health Diagnostics Market Size by Type (2016-2027)
8.3 Asia-Pacific Women Health Diagnostics Market Size by Application
8.3.1 Asia-Pacific Women Health Diagnostics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Women Health Diagnostics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Women Health Diagnostics Market Size by Application (2016-2027)
8.4 Asia-Pacific Women Health Diagnostics Market Size by Region
8.4.1 Asia-Pacific Women Health Diagnostics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Women Health Diagnostics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Women Health Diagnostics Market Size (2016-2027)
9.2 Latin America Women Health Diagnostics Market Size by Type
9.2.1 Latin America Women Health Diagnostics Market Size by Type (2016-2021)
9.2.2 Latin America Women Health Diagnostics Market Size by Type (2022-2027)
9.2.3 Latin America Women Health Diagnostics Market Size by Type (2016-2027)
9.3 Latin America Women Health Diagnostics Market Size by Application
9.3.1 Latin America Women Health Diagnostics Market Size by Application (2016-2021)
9.3.2 Latin America Women Health Diagnostics Market Size by Application (2022-2027)
9.3.3 Latin America Women Health Diagnostics Market Size by Application (2016-2027)
9.4 Latin America Women Health Diagnostics Market Size by Country
9.4.1 Latin America Women Health Diagnostics Market Size by Country (2016-2021)
9.4.2 Latin America Women Health Diagnostics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Women Health Diagnostics Market Size (2016-2027)
10.2 Middle East & Africa Women Health Diagnostics Market Size by Type
10.2.1 Middle East & Africa Women Health Diagnostics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Women Health Diagnostics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Women Health Diagnostics Market Size by Type (2016-2027)
10.3 Middle East & Africa Women Health Diagnostics Market Size by Application
10.3.1 Middle East & Africa Women Health Diagnostics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Women Health Diagnostics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Women Health Diagnostics Market Size by Application (2016-2027)
10.4 Middle East & Africa Women Health Diagnostics Market Size by Country
10.4.1 Middle East & Africa Women Health Diagnostics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Women Health Diagnostics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Quest Diagnostics
11.1.1 Quest Diagnostics Company Details
11.1.2 Quest Diagnostics Business Overview
11.1.3 Quest Diagnostics Women Health Diagnostics Introduction
11.1.4 Quest Diagnostics Revenue in Women Health Diagnostics Business (2016-2021)
11.1.5 Quest Diagnostics Recent Development
11.2 Abbott
11.2.1 Abbott Company Details
11.2.2 Abbott Business Overview
11.2.3 Abbott Women Health Diagnostics Introduction
11.2.4 Abbott Revenue in Women Health Diagnostics Business (2016-2021)
11.2.5 Abbott Recent Development
11.3 BD
11.3.1 BD Company Details
11.3.2 BD Business Overview
11.3.3 BD Women Health Diagnostics Introduction
11.3.4 BD Revenue in Women Health Diagnostics Business (2016-2021)
11.3.5 BD Recent Development
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche Women Health Diagnostics Introduction
11.4.4 Roche Revenue in Women Health Diagnostics Business (2016-2021)
11.4.5 Roche Recent Development
11.5 GE Healthcare
11.5.1 GE Healthcare Company Details
11.5.2 GE Healthcare Business Overview
11.5.3 GE Healthcare Women Health Diagnostics Introduction
11.5.4 GE Healthcare Revenue in Women Health Diagnostics Business (2016-2021)
11.5.5 GE Healthcare Recent Development
11.6 Biomerieux
11.6.1 Biomerieux Company Details
11.6.2 Biomerieux Business Overview
11.6.3 Biomerieux Women Health Diagnostics Introduction
11.6.4 Biomerieux Revenue in Women Health Diagnostics Business (2016-2021)
11.6.5 Biomerieux Recent Development
11.7 Philips
11.7.1 Philips Company Details
11.7.2 Philips Business Overview
11.7.3 Philips Women Health Diagnostics Introduction
11.7.4 Philips Revenue in Women Health Diagnostics Business (2016-2021)
11.7.5 Philips Recent Development
11.8 DIALAB
11.8.1 DIALAB Company Details
11.8.2 DIALAB Business Overview
11.8.3 DIALAB Women Health Diagnostics Introduction
11.8.4 DIALAB Revenue in Women Health Diagnostics Business (2016-2021)
11.8.5 DIALAB Recent Development
11.9 Fujifilm
11.9.1 Fujifilm Company Details
11.9.2 Fujifilm Business Overview
11.9.3 Fujifilm Women Health Diagnostics Introduction
11.9.4 Fujifilm Revenue in Women Health Diagnostics Business (2016-2021)
11.9.5 Fujifilm Recent Development
11.10 GenMark
11.10.1 GenMark Company Details
11.10.2 GenMark Business Overview
11.10.3 GenMark Women Health Diagnostics Introduction
11.10.4 GenMark Revenue in Women Health Diagnostics Business (2016-2021)
11.10.5 GenMark Recent Development
11.11 Hologic
11.11.1 Hologic Company Details
11.11.2 Hologic Business Overview
11.11.3 Hologic Women Health Diagnostics Introduction
11.11.4 Hologic Revenue in Women Health Diagnostics Business (2016-2021)
11.11.5 Hologic Recent Development
11.12 Luminex
11.12.1 Luminex Company Details
11.12.2 Luminex Business Overview
11.12.3 Luminex Women Health Diagnostics Introduction
11.12.4 Luminex Revenue in Women Health Diagnostics Business (2016-2021)
11.12.5 Luminex Recent Development
11.13 Nova Biomedical
11.13.1 Nova Biomedical Company Details
11.13.2 Nova Biomedical Business Overview
11.13.3 Nova Biomedical Women Health Diagnostics Introduction
11.13.4 Nova Biomedical Revenue in Women Health Diagnostics Business (2016-2021)
11.13.5 Nova Biomedical Recent Development
11.14 PerkinElmer
11.14.1 PerkinElmer Company Details
11.14.2 PerkinElmer Business Overview
11.14.3 PerkinElmer Women Health Diagnostics Introduction
11.14.4 PerkinElmer Revenue in Women Health Diagnostics Business (2016-2021)
11.14.5 PerkinElmer Recent Development
11.15 Siemens Healthineers
11.15.1 Siemens Healthineers Company Details
11.15.2 Siemens Healthineers Business Overview
11.15.3 Siemens Healthineers Women Health Diagnostics Introduction
11.15.4 Siemens Healthineers Revenue in Women Health Diagnostics Business (2016-2021)
11.15.5 Siemens Healthineers Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Women Health Diagnostics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Breast cancer testing
Table 3. Key Players of Cervical cancer testing
Table 4. Key Players of Osteoporosis testing
Table 5. Key Players of Pregnancy & fertility testing
Table 6. Key Players of Ovarian cancer testing
Table 7. Key Players of Infectious disease testing
Table 8. Key Players of Prenatal genetic screening and carrier testing
Table 9. Key Players of Ultrasound tests
Table 10. Key Players of HIV testing
Table 11. Global Women Health Diagnostics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 12. Global Women Health Diagnostics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 13. Global Women Health Diagnostics Market Size by Regions (2016-2021) & (US$ Million)
Table 14. Global Women Health Diagnostics Market Share by Regions (2016-2021)
Table 15. Global Women Health Diagnostics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 16. Global Women Health Diagnostics Market Share by Regions (2022-2027)
Table 17. Women Health Diagnostics Market Trends
Table 18. Women Health Diagnostics Market Drivers
Table 19. Women Health Diagnostics Market Challenges
Table 20. Women Health Diagnostics Market Restraints
Table 21. Global Women Health Diagnostics Revenue by Players (2016-2021) & (US$ Million)
Table 22. Global Women Health Diagnostics Market Share by Players (2016-2021)
Table 23. Global Top Women Health Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Women Health Diagnostics as of 2020)
Table 24. Ranking of Global Top Women Health Diagnostics Companies by Revenue (US$ Million) in 2020
Table 25. Global 5 Largest Players Market Share by Women Health Diagnostics Revenue (CR5 and HHI) & (2016-2021)
Table 26. Key Players Headquarters and Area Served
Table 27. Key Players Women Health Diagnostics Product Solution and Service
Table 28. Date of Enter into Women Health Diagnostics Market
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Women Health Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 31. Global Women Health Diagnostics Revenue Market Share by Type (2016-2021)
Table 32. Global Women Health Diagnostics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 33. Global Women Health Diagnostics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 34. Global Women Health Diagnostics Market Size Share by Application (2016-2021) & (US$ Million)
Table 35. Global Women Health Diagnostics Revenue Market Share by Application (2016-2021)
Table 36. Global Women Health Diagnostics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 37. Global Women Health Diagnostics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 38. North America Women Health Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 39. North America Women Health Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 40. North America Women Health Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 41. North America Women Health Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 42. North America Women Health Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 43. North America Women Health Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 44. Europe Women Health Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 45. Europe Women Health Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 46. Europe Women Health Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 47. Europe Women Health Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 48. Europe Women Health Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 49. Europe Women Health Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Women Health Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 51. Asia-Pacific Women Health Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 52. Asia-Pacific Women Health Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 53. Asia-Pacific Women Health Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 54. Asia-Pacific Women Health Diagnostics Market Size by Region (2016-2021) & (US$ Million)
Table 55. Asia-Pacific Women Health Diagnostics Market Size by Region (2022-2027) & (US$ Million)
Table 56. Latin America Women Health Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 57. Latin America Women Health Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 58. Latin America Women Health Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 59. Latin America Women Health Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 60. Latin America Women Health Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 61. Latin America Women Health Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Women Health Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 63. Middle East & Africa Women Health Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 64. Middle East & Africa Women Health Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 65. Middle East & Africa Women Health Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 66. Middle East & Africa Women Health Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 67. Middle East & Africa Women Health Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 68. Quest Diagnostics Company Details
Table 69. Quest Diagnostics Business Overview
Table 70. Quest Diagnostics Women Health Diagnostics Product
Table 71. Quest Diagnostics Revenue in Women Health Diagnostics Business (2016-2021) & (US$ Million)
Table 72. Quest Diagnostics Recent Development
Table 73. Abbott Company Details
Table 74. Abbott Business Overview
Table 75. Abbott Women Health Diagnostics Product
Table 76. Abbott Revenue in Women Health Diagnostics Business (2016-2021) & (US$ Million)
Table 77. Abbott Recent Development
Table 78. BD Company Details
Table 79. BD Business Overview
Table 80. BD Women Health Diagnostics Product
Table 81. BD Revenue in Women Health Diagnostics Business (2016-2021) & (US$ Million)
Table 82. BD Recent Development
Table 83. Roche Company Details
Table 84. Roche Business Overview
Table 85. Roche Women Health Diagnostics Product
Table 86. Roche Revenue in Women Health Diagnostics Business (2016-2021) & (US$ Million)
Table 87. Roche Recent Development
Table 88. GE Healthcare Company Details
Table 89. GE Healthcare Business Overview
Table 90. GE Healthcare Women Health Diagnostics Product
Table 91. GE Healthcare Revenue in Women Health Diagnostics Business (2016-2021) & (US$ Million)
Table 92. GE Healthcare Recent Development
Table 93. Biomerieux Company Details
Table 94. Biomerieux Business Overview
Table 95. Biomerieux Women Health Diagnostics Product
Table 96. Biomerieux Revenue in Women Health Diagnostics Business (2016-2021) & (US$ Million)
Table 97. Biomerieux Recent Development
Table 98. Philips Company Details
Table 99. Philips Business Overview
Table 100. Philips Women Health Diagnostics Product
Table 101. Philips Revenue in Women Health Diagnostics Business (2016-2021) & (US$ Million)
Table 102. Philips Recent Development
Table 103. DIALAB Company Details
Table 104. DIALAB Business Overview
Table 105. DIALAB Revenue in Women Health Diagnostics Business (2016-2021) & (US$ Million)
Table 106. DIALAB Recent Development
Table 107. Fujifilm Company Details
Table 108. Fujifilm Business Overview
Table 109. Fujifilm Women Health Diagnostics Product
Table 110. Fujifilm Revenue in Women Health Diagnostics Business (2016-2021) & (US$ Million)
Table 111. Fujifilm Recent Development
Table 112. GenMark Company Details
Table 113. GenMark Business Overview
Table 114. GenMark Women Health Diagnostics Product
Table 115. GenMark Revenue in Women Health Diagnostics Business (2016-2021) & (US$ Million)
Table 116. GenMark Recent Development
Table 117. Hologic Company Details
Table 118. Hologic Business Overview
Table 119. Hologic Women Health Diagnostics Product
Table 120. Hologic Revenue in Women Health Diagnostics Business (2016-2021) & (US$ Million)
Table 121. Hologic Recent Development
Table 122. Luminex Company Details
Table 123. Luminex Business Overview
Table 124. Luminex Women Health Diagnostics Product
Table 125. Luminex Revenue in Women Health Diagnostics Business (2016-2021) & (US$ Million)
Table 126. Luminex Recent Development
Table 127. Nova Biomedical Company Details
Table 128. Nova Biomedical Business Overview
Table 129. Nova Biomedical Women Health Diagnostics Product
Table 130. Nova Biomedical Revenue in Women Health Diagnostics Business (2016-2021) & (US$ Million)
Table 131. Nova Biomedical Recent Development
Table 132. PerkinElmer Company Details
Table 133. PerkinElmer Business Overview
Table 134. PerkinElmer Women Health Diagnostics Product
Table 135. PerkinElmer Revenue in Women Health Diagnostics Business (2016-2021) & (US$ Million)
Table 136. PerkinElmer Recent Development
Table 137. Siemens Healthineers Company Details
Table 138. Siemens Healthineers Business Overview
Table 139. Siemens Healthineers Women Health Diagnostics Product
Table 140. Siemens Healthineers Revenue in Women Health Diagnostics Business (2016-2021) & (US$ Million)
Table 141. Siemens Healthineers Recent Development
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Women Health Diagnostics Market Share by Type: 2020 VS 2027
Figure 2. Breast cancer testing Features
Figure 3. Cervical cancer testing Features
Figure 4. Osteoporosis testing Features
Figure 5. Pregnancy & fertility testing Features
Figure 6. Ovarian cancer testing Features
Figure 7. Infectious disease testing Features
Figure 8. Prenatal genetic screening and carrier testing Features
Figure 9. Ultrasound tests Features
Figure 10. HIV testing Features
Figure 11. Global Women Health Diagnostics Market Share by Application: 2020 VS 2027
Figure 12. Diagnostic and imaging centers Case Studies
Figure 13. Hospitals and clinics Case Studies
Figure 14. Home care Case Studies
Figure 15. Women Health Diagnostics Report Years Considered
Figure 16. Global Women Health Diagnostics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 17. Global Women Health Diagnostics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 18. Global Women Health Diagnostics Market Share by Regions: 2020 VS 2027
Figure 19. Global Women Health Diagnostics Market Share by Regions (2022-2027)
Figure 20. Global Women Health Diagnostics Market Share by Players in 2020
Figure 21. Global Top Women Health Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Women Health Diagnostics as of 2020
Figure 22. The Top 10 and 5 Players Market Share by Women Health Diagnostics Revenue in 2020
Figure 23. Global Women Health Diagnostics Revenue Market Share by Type (2016-2021)
Figure 24. Global Women Health Diagnostics Revenue Market Share by Type (2022-2027)
Figure 25. North America Women Health Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. North America Women Health Diagnostics Market Share by Type (2016-2027)
Figure 27. North America Women Health Diagnostics Market Share by Application (2016-2027)
Figure 28. North America Women Health Diagnostics Market Share by Country (2016-2027)
Figure 29. United States Women Health Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Canada Women Health Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Women Health Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Europe Women Health Diagnostics Market Share by Type (2016-2027)
Figure 33. Europe Women Health Diagnostics Market Share by Application (2016-2027)
Figure 34. Europe Women Health Diagnostics Market Share by Country (2016-2027)
Figure 35. Germany Women Health Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. France Women Health Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. U.K. Women Health Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Italy Women Health Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Russia Women Health Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Nordic Women Health Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Women Health Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Asia-Pacific Women Health Diagnostics Market Share by Type (2016-2027)
Figure 43. Asia-Pacific Women Health Diagnostics Market Share by Application (2016-2027)
Figure 44. Asia-Pacific Women Health Diagnostics Market Share by Region (2016-2027)
Figure 45. China Women Health Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Japan Women Health Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. South Korea Women Health Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Southeast Asia Women Health Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. India Women Health Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Australia Women Health Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Women Health Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Latin America Women Health Diagnostics Market Share by Type (2016-2027)
Figure 53. Latin America Women Health Diagnostics Market Share by Application (2016-2027)
Figure 54. Latin America Women Health Diagnostics Market Share by Country (2016-2027)
Figure 55. Mexico Women Health Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Brazil Women Health Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Women Health Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Middle East & Africa Women Health Diagnostics Market Share by Type (2016-2027)
Figure 59. Middle East & Africa Women Health Diagnostics Market Share by Application (2016-2027)
Figure 60. Middle East & Africa Women Health Diagnostics Market Share by Country (2016-2027)
Figure 61. Turkey Women Health Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Saudi Arabia Women Health Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. UAE Women Health Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 64. Quest Diagnostics Revenue Growth Rate in Women Health Diagnostics Business (2016-2021)
Figure 65. Abbott Revenue Growth Rate in Women Health Diagnostics Business (2016-2021)
Figure 66. BD Revenue Growth Rate in Women Health Diagnostics Business (2016-2021)
Figure 67. Roche Revenue Growth Rate in Women Health Diagnostics Business (2016-2021)
Figure 68. GE Healthcare Revenue Growth Rate in Women Health Diagnostics Business (2016-2021)
Figure 69. Biomerieux Revenue Growth Rate in Women Health Diagnostics Business (2016-2021)
Figure 70. Philips Revenue Growth Rate in Women Health Diagnostics Business (2016-2021)
Figure 71. DIALAB Revenue Growth Rate in Women Health Diagnostics Business (2016-2021)
Figure 72. Fujifilm Revenue Growth Rate in Women Health Diagnostics Business (2016-2021)
Figure 73. GenMark Revenue Growth Rate in Women Health Diagnostics Business (2016-2021)
Figure 74. Hologic Revenue Growth Rate in Women Health Diagnostics Business (2016-2021)
Figure 75. Luminex Revenue Growth Rate in Women Health Diagnostics Business (2016-2021)
Figure 76. Nova Biomedical Revenue Growth Rate in Women Health Diagnostics Business (2016-2021)
Figure 77. PerkinElmer Revenue Growth Rate in Women Health Diagnostics Business (2016-2021)
Figure 78. Siemens Healthineers Revenue Growth Rate in Women Health Diagnostics Business (2016-2021)
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed
世界の出生前遺伝子検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Prenatal Genetic Testing Market The global Prenatal Genetic Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the …- 世界の乳がん予測遺伝子検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Breast Cancer Predictive Genetic Testing Market The global Breast Cancer Predictive Genetic Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analys…
- 世界の妊娠前遺伝子検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Pre-Pregnancy Genetic Testing Market The global Pre-Pregnancy Genetic Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integ…
- 世界の出生前検査市場規模・現状・予測（2021年-2027年） Prenatal testing consists of prenatal screening and prenatal diagnosis, which are aspects of prenatal care that focus on detecting problems with the pregnancy as early as possible. Prenatal screening can detect problems such as neural tube defects, chromosome abnormalities, and it can also detect an…
- 世界のがん検診/スクリーニング市場規模・現状・予測（2021年-2027年） Screening means checking your body for cancer before you have symptoms. In the recent years, Next Generation Sequencing (NGS) is being widely used for detection of various types of cancer. Market Analysis and Insights: Global Cancer Testing/Screening Market The global Cancer Testing/Screening market…